Most of the CF patients followed at referral centers in Brazil have class I or II mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, all of which are associated with severe forms of CF that lead to multisystem involvement.6 The gene discussed is CFTR; the disease is cystic fibrosis.